[Effect of hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer]. 2002

Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
Dept. of Surgery, Yokosuka Kyousai Hospital.

We performed hepatic arterial infusion (HAI) chemotherapy for 4 patients with advanced gastric cancer who had undergone curative resection except for liver metastasis. The main antineoplastic drugs were 5-fluorouracil (5-FU), mitomycin C (MMC) and cisplatin (CDDP). A catheter was inserted into the hepatic artery by interventional radiological techniques in 3 patients and operatively in 1 patient. The response rate for 4 patients was 75% (CR2, PR1, PD1). The adverse events were Grade 3/4 nausea and/or vomiting in 2 cases. The HAI chemotherapy was effective and useful for patients with advanced gastric cancer who had no unresectable lesions except for liver metastasis.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
October 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
January 2004, Cancer investigation,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
October 2003, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
September 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
October 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
July 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
May 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
October 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Ryoichi Shizawa, and Yutaka Nagahori, and Nobufumi Kumamoto, and Harumi Yamamoto, and Kazunaga Takeda, and Youhei Hamaguchi, and Tadao Fukushima, and Masayoshi Yamamoto, and Masatoshi Mogaki, and Shingo Fukasawa, and Kazuya Eguchi, and Masaki Kawahara, and Kaoru Nagahori, and Hideo Hosoi, and Takeshi Ohara
September 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!